Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 44: 1191-1197, 1998;
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Bricon, T.
Right arrow Articles by Bousquet, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Bricon, T.
Right arrow Articles by Bousquet, B.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 1998;44:1191-1197.)
© 1998 American Association for Clinical Chemistry, Inc.


Enzymes and Protein Markers

Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: application to multiple myeloma

Thierry Le Bricon1,a, Danielle Erlich1, Djaouida Bengoufa2, Michelle Dussaucy1, Jean-Pierre Garnier1, and Bernard Bousquet1

1 Laboratoires de Biochimie A et B and
2 Laboratoire d'Immunologie, Hôpital St-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France.
a Author for correspondence. Fax 33 1 42 49 92 47; e-mail Biochimie-a{at}chu-stlouis.fr.


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
We evaluated a new sodium dodecyl sulfate-agarose gel electrophoresis (SDS-AGE) for urinary protein analysis in patients with multiple myeloma (MM; n = 47; ages, 62 ± 2 years, mean ± SE). Abnormal proteinuria (mean = 1872 ± 360 mg/24 h) was present in 95% of the samples; 75% of the patients had some sign of renal dysfunction (glomerular and/or tubular) according to their SDS-AGE pattern. A band suggesting Bence Jones proteinuria (BJP) was detected in 40 vs 33 specimens by routine AGE. Immunofixation identified BJP in 38 patients; the calculated sensitivity of SDS-AGE for BJP was 97%. Excellent correlation (P <0.0001) was obtained with routine AGE (r = 0.994) and immunonephelometry (r = 0.963) for light chain quantification. SDS-AGE allows easy evaluation of renal dysfunction and shows high sensitivity for BJP detection. In a specialized laboratory, it is useful for following the progress of MM patients through the semiquantification of BJP.


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Urinary investigations for patients with multiple myeloma (MM)1 include electrophoretic protein screening (evaluation of renal function, detection of an abnormal protein fraction) followed by immunofixation (IFE) for identification of a monoclonal component [intact immunoglobulin or monoclonal free light chains: Bence Jones proteinuria (BJP)] (1). BJP is detected in the urine of 75% of MM patients and is one of the major laboratory features of this disease (2)(3). Quantitation of BJP by electrophoresis is also used to monitor renal complications of the disease (3) and response to therapy (the amount of Bence Jones proteins excreted in the urine correlates with tumor mass) (4).

Electrophoretic methods (agarose or cellulose acetate) are used routinely for analysis of urinary proteins on the basis of charge and molecular size. These methods require prior concentration of urine, usually by ultrafiltration, which is time-consuming and expensive and may lead to protein loss (5)(6). Some results are particularly difficult to interpret because Bence Jones proteins may comigrate with intact immunoglobulins and other proteins (such as transferrin) (7). Routine agarose electrophoresis (AGE) also shows poor sensitivity for detecting small concentrations of Bence Jones proteins (1).

Recently, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) has been introduced for qualitative analysis of urinary proteins. SDS-PAGE separates proteins according to their molecular size (8), and free light chain monomers (polyclonal or monoclonal) are visualized as a band of Mr 25 000, easily distinguished from intact immunoglobulins (Mr 150 000). SDS-PAGE also differentiates proteinuria of glomerular (proteins with a Mr >66 000), tubular (Mr <66 000), or mixed origin. This method is thus a potentially powerful clinical tool for assessing kidney function, an important prognostic factor in MM (9)(10). SDS-PAGE, however, is not widely used in clinical laboratories because it is technically demanding, time-consuming, and expensive (11)(12)(13)(14).

In this study, we evaluated, for the first time, a new SDS-agarose gel electrophoresis (SDS-AGE) for analysis of proteins in the urine of patients with MM. Results were compared with those obtained by routine (nondenaturing) AGE and IFE. Free and bound light chains ({kappa},{lambda}), IgG, and albumin were measured by immunonephelometry.


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
patients
We studied 47 consecutive patients (mean age, 62 ± 2 years; male, n = 26; female, n = 21) with known MM. In 29 patients (62%), an abnormal fraction was present in the serum (range, 1.0–70.9 g/L, determined by AGE). The serum monoclonal immunoglobulins identified by IFE were IgG, n = 34; IgA, n = 11; and IgD, n = 1; there was one case of light chain disease. We evaluated a control group of 30 consecutive patients (ages, 15–85 years; male, n = 16; female, n = 14) without hematological disorder to assess the specificity of SDS-AGE for BJP. Their urine samples were examined in our laboratory by electrophoresis of urinary proteins; all tested negative for BJP by IFE. All procedures were in accordance with the Helsinki Declaration of 1975, as revised in 1983.

urinary samples
Samples from 24-h urines were collected in 25-mL Monovette® tubes without additive (Sarstedt) and centrifuged for 5 min at 1500g (4 °C) before screening for blood and protein (detection limit, 150 mg/L) by Multistix® dipstick tests (Bayer Diagnostics). Samples were then stored at -20 °C. Before analysis, urine was resuspended and centrifuged as described above.

analysis
Routine AGE.
Before routine AGE, urine was concentrated 25-fold by ultrafiltration in Minicon® chambers (Amicon). The time required for urine concentration by ultrafiltration varied from 30 min to 4 h. Concentrated urine was analyzed using the Hydragel® kit on an Hydrasis® automated gel electrophoresis apparatus (Sebia). Briefly, 10 µL of concentrated urine was applied in each well (15 wells/gel) and run at 272 V (68 mA) at 20 °C for 7 min. After the gels were dried at 65 °C for 10 min, they were stained with 5 g/L amido schwarz in a 50 mL/L acetic acid solution for 4 min and destained before a final drying at 75 °C for 8 min. Total analysis time for electrophoresis was 45 min.

The gels were then scanned with a Preference® densitometer (Sebia) using a yellow filter (570 nm) for determination of five different fractions: albumin, {alpha}1-globulin, {alpha}2-globulin, ß-globulin, and {gamma}-globulin. A serum protein control, Precinorm® (Boehringer), was run in parallel with urine specimens on each gel for appropriate separation of different fractions. Abnormal fractions present in the {gamma}- or ß-globulin zones of the gel were individually integrated and expressed in percentage of total proteinuria and in g/L.

SDS-AGE.
Urine was analyzed by SDS-AGE using the Hydragel proteinurie® kit (Sebia), without prior concentration. Urine containing >2 g protein/L was diluted with 9 g/L NaCl to 1 g/L before analysis, according to the manufacturer's recommendations. Twenty microliters of a 10 g/L SDS solution (with bromphenol blue as a marker) were added to 80 µL of urine and briefly vortex-mixed at room temperature. Five microliters of the treated samples were added to each well (5 wells/gel) and allowed to diffuse for 10 min. A constant voltage of 60 V (10 mA) was applied to the gel for 60 min in an SDS–imidazole (1.0 g/L of SDS and 3.4 g/L imidazole) buffer (150 mL/compartment) by use of a MG 500 power source (Sebia). After the gel was completely dried at 80 °C for 20 min, it was immersed for 30 min in the following aqueous staining solution: 1.33 g/L coomassie blue, 250 mL/L methanol, and 200 mL/L acetic acid. The gel was destained in two successive aqueous baths of 150 mL/L acetic acid before it was immersed in a 150 mL/L glycerol aqueous solution and dried at 80 °C (15 min). Total analysis time was 3.5 h.

On the gel, we detected immunoglobulins (Mr 850 000–150 000), haptoglobin (Mr 86 000), transferrin (Mr 76 000), albumin (Mr 66 000), {alpha}1-microglobulin (Mr 30 000), light chain monomers (Mr 25 000), retinol-binding protein (Mr 21 000), and ß2-microglobulin (Mr 12 000). Polyclonal light chains could not be distinguished from monoclonal light chains. SDS-AGE differentiated physiological proteinuria (<150 mg/24 h, mainly albumin) and proteinuria from renal (glomerular, tubular, or mixed) or prerenal origin (Table 1 ). Five selected SDS-AGE patterns are presented in Fig. 1 . Monoclonal light chains (BJP) appear as a broad intense band at Mr 25 000 and can be found in the absence (pure prerenal BJP) or in the presence of renal proteinuria.


View this table:
[in this window]
[in a new window]
 
Table 1. Type of proteinuria according to the SDS-agarose electrophoresis pattern.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 1. Selected electrophoretic patterns obtained by SDS-AGE.

From left to right: 1, glomerular-selective proteinuria: transferrin and albumin; 2, pure prerenal BJP: light chain dimers and monomers before ß-ME treatment; 3, mixed proteinuria: immunoglobulins (Ig), transferrin (Trf), albumin (Alb), {alpha}1-microglobulin (Alpha-1 µ), light chain monomers (polyclonal), retinol-binding protein (RBP), and ß2-microglobulin (Beta-2 µ); 4, pure prerenal BJP: light chain monomers; 5, tubular proteinuria: small amounts of albumin, light chain monomers (polyclonal), and RBP. The monoclonal character of detected light chains was confirmed by IFE.

Urine containing polymeric forms of light chains was pretreated with ß-mercaptoethanol (ß-ME) before electrophoresis. Five microliters of 100 mL/L ß-ME were added to 100 µL of urine and briefly vortex-mixed at room temperature. A 5-µL sample was loaded onto the gel and allowed to diffuse for 10 min before electrophoresis. After electrophoresis was complete, the gels were scanned, and the results were expressed as a percentage of total proteinuria and in g/L. The stated detection limit for a band was 15 mg/L (manufacturer's data).

A protein Mr marker LMW® (Pharmacia Biotech) suitable for SDS-PAGE was run on each gel. Band relative mobility (Rf) compared with lactalbumin (Mr 14 000) was calculated for each LMW protein (phosphorylase b, Mr 94 000; albumin, Mr 67 000; ovalbumin, Mr 43 000; carbonic anhydrase, Mr 30 000; and trypsin inhibitor, Mr 20 000) in nine different gels on separate days to evaluate the reproducibility of electrophoretic separations. Two urine samples containing high (pure prerenal BJP; light chains, 500 mg/L) and low (tubular proteinuria; light chains, 50 mg/L) concentrations of light chains were selected for estimation of the precision (within-run and day-to-day CV, n = 9 for each). The high control was treated with ß-ME before electrophoresis.

Other biochemical analyses.
Total protein was determined on a Hitachi 747® analyzer (Boehringer) by an SDS-pyrogallol red-molybdate technique (Merck-Clevenot) (15)(16). The concentrations of urinary albumin, immunoglobulin G (IgG), and free and bound light chains kappa (L{kappa}) and lambda (L{lambda}) were measured by laser immunonephelometry on a BNII® analyzer (Behring) (17)(18)(19). The urinary L{kappa}/L{lambda} ratio was calculated (usual values, 1.0 < ratio < 5.2); urinary samples with ratios outside this reference are likely to contain monoclonal light chains (Bence Jones proteins). IFE was performed using the Paragon® IFE kit (Beckman). Samples with total proteinuria <300 mg/L were concentrated up to 100-fold by ultrafiltration in Minicon chambers before IFE.

statistical analysis
Results are expressed as mean and SE. Because population distribution was not gaussian, differences between groups were assessed by the Kruskal–Wallis ANOVA, followed by the Dunn's procedure for multiple comparisons. Correlations between techniques and biological parameters were evaluated by linear regression and ANOVA. Statistical significance was set at P <0.05.


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
total proteinuria, immunonephelometry, and ife
Abnormal 24-h proteinuria (>150 mg/24 h; mean, 1872 ± 360 mg/24 h) was found in 95% of the MM patients, with large variations among individuals (136–11475 mg/24 h). In the control group, total proteinuria ranged from 40 to 18430 mg/24 h (mean, 1840 ± 644 mg/24 h, not significantly different from MM patients); 6 of 30 patients had physiological proteinuria (117 ± 18 mg/24 h). In MM patients, urinary albumin excretion ranged from <20 mg/24 h (n = 5) to macroalbuminuria (>300 mg/24 h, n = 10). In all but 1 of the 47 MM patients, free and/or bound light chains were detected by immunonephelometry (range, 6–4670 mg/L). Eight had a L{kappa}/L{lambda} ratio within the normal reference interval; 20 had a ratio >5.2; and 18 had a ratio <1. Intact IgG was found in 66% of urine specimens (range, 4–187 mg/L). Urinary BJP was detected by IFE in 38 of 47 urinary samples (L{kappa}, n = 20; L{lambda}, n = 18).

routine age
Albumin values obtained by electrophoresis were significantly higher than those measured by immunonephelometry (187 ± 33 vs 145 ± 26 mg/L, P <0.05); the two techniques correlated significantly for this parameter (r = 0.958, P <0.0001). In ~75% of cases, poor resolution was obtained in the {alpha}1-globulin, {alpha}2-globulin, and ß-globulin zones of the gel. An abnormal fraction, which suggested BJP, was detected in the ß- or {gamma}-globulin zones of the gel in 33 of 47 urine samples (70% of cases) and represented 4–95% of the total proteinuria. A significant correlation (r = 0.950, P <0.0001) was noted between this fraction (662 ± 188 mg/L) and light chains measured by immunonephelometry (L{kappa} and L{lambda}, 953 ± 345 mg/L). Samples with an abnormal fraction detected by routine electrophoresis were all positive for BJP by IFE (no false positives). Detailed analysis of 14 negative MM patients by routine electrophoresis is presented in Table 2 .In four specimens, protein was <150 mg/L. For the remaining 10 samples, protein concentrations ranged from 180 to 2080 mg/L and consisted of a complex mixture of albumin, {alpha}1-globulin, {alpha}2-globulin, ß-globulin, and {gamma}-globulin. In 10 cases, light chains measured by immunonephelometry were <50 mg/L; one of these had no detectable light chains. BJP {kappa} was identified by IFE in five cases (five false negatives for routine electrophoresis); therefore, the calculated sensitivity for BJP detection was 87% (33 of 38 patients).


View this table:
[in this window]
[in a new window]
 
Table 2. Urine specimens from MM patients negative by routine AGE analyzed by immunonephelometry, SDS-AGE, and IFE.

sds-age
The migration of the molecular weight markers and a urine sample with mixed proteinuria and BJP (identified by IFE) is presented in Fig. 2 . The mean CV for the Rf of the reference proteins (LMW control) was 2.7%, ranging from 1.3% (trypsin inhibitor) to 4.0% (albumin). The within-run CV for light chain quantitation was 1% for the high control and 4% for the low control (n = 9). The day-to-day CV was 2% and 5% for high and low controls, respectively (9 days).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 2. Migration of urinary proteins in SDS-AGE.

The migration of the molecular weight marker LMW (Pharmacia) (A) and of a urinary specimen with a mixed proteinuria with BJP (B) is presented. Band Rf compared with lactalbumin (Mr 14 400) was calculated for each LMW protein (phosphorylase b, Mr 94 000; albumin, Mr 67 000; ovalbumin, Mr 43 000; carbonic anhydrase, Mr 30 000; and trypsin inhibitor, Mr 20 000). The MM patient (male; age, 64 years; monoclonal IgG {lambda}) excreted 3.0 g protein/24 h (1.0 g/L), consisting of a mixture of albumin (0.3 g/L), IgG (0.1 g/L), L {lambda} (0.48 g/L), and other proteins. The band corresponding to the light chain monomers represented 20% of total proteinuria. Intact monoclonal IgG and BJP {lambda} were identified by IFE.

Fifty percent of the patients from the control group had a mixed proteinuria, according to their SDS-AGE pattern (Table 1Up ). The mean proteinuria in this group was 2630 ± 1190 mg protein/24 h. Eight samples were identified as glomerular proteinuria, either selective (n = 5) or not selective (n = 3); the total protein was 390 ± 88 and 4500 ± 133 mg/24 h, respectively. There was one case of tubular proteinuria (540 mg protein/24 h) and six cases of physiological proteinuria (<150 mg protein/24 h). Polyclonal free light chain monomers were detected in all urine samples with mixed and tubular proteinuria (n = 16), but there was no evidence of BJP in the control group. This was confirmed by IFE (no false positives).

In MM patients, SDS-AGE patterns were glomerular (n = 13), tubular (n = 9), mixed (n = 13), or prerenal BJP (n = 12), according to criteria summarized in Table 1Up . Patients with proteinuria of mixed origin excreted significantly (P <0.05) more albumin (453 ± 120 mg/24 h) than those with tubular (76 ± 26 mg/24 h) or prerenal proteinuria (74 ± 19 mg/24 h), as determined by immunonephelometry. A band suggesting BJP was detected in 40 of 47 MM patients (85%), including 8 that were negative in routine electrophoresis (Table 2Up ). IFE detected BJP in 37 of these 40 samples (3 false positives). Among negative SDS-PAGE samples (n = 7), IFE detected BJP {lambda} in one (one false negative). Selected gels from urinary samples that were difficult to interpret by routine electrophoresis are presented in Fig. 3 . Specimens with polymeric forms of light chains (47% of cases) were treated with ß-ME before quantification (Fig. 4 ). A significant correlation (r = 0.963, P <0.0001) was found between light chains detected by SDS-AGE (661 ± 204 mg/L) and those measured by immunonephelometry. The two electrophoresis techniques also correlated significantly for light chains (in mg/L): SDS-agarose = 0.9682 x routine agarose - 74.696, r = 0.994, P <0.0001.



View larger version (54K):
[in this window]
[in a new window]
 
Figure 3. A comparison between routine and SDS-AGE for selected urinary samples from MM patients.

(Top) Selected urinary samples difficult to interpret by routine electrophoresis. From left to right: 1, poor resolution of {alpha}1- and {alpha}2-globulin; 2, undetermined fraction in {alpha}1-globulin, possible small fraction in {gamma}-globulin; 3, poor sensitivity (predominance of albumin); 4, abnormal fraction in {gamma}-globulin, difficult to quantitate; 5, poor sensitivity (predominance of albumin). (Bottom) With SDS-AGE, samples were easily classified, from left to right: 1, mixed proteinuria, no BJP; 2, glomerular proteinuria with BJP (20% of total proteinuria) and intact immunoglobulin (Ig); 3, pure prerenal BJP, 26% of total proteinuria as light chain; 4, pure prerenal BJP, 60% of total proteinuria as light chain; 5, tubular proteinuria with BJP. Absence or presence of BJP was confirmed by IFE.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 4. Effect of ß-ME treatment on SDS-AGE pattern of BJP-positive sample.

A MM patient (female; age, 70 years) excreted 3.0 g protein/24 h (1.5 g/L). Complete analysis of proteinuria gave the following results: dipstick test + (0.3 g/L protein); albuminuria, 0.28 g/L; L {kappa}, 1240 mg/L; L {lambda}, not detected; abnormal fraction in the {gamma}-globulin zone of the gel by routine electrophoresis, 72% of proteinuria. In SDS-AGE, the band corresponding to the light chain monomers was 30% of proteinuria before and 68% after treatment with 100 mL/L ß-Me.


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
We evaluated, for the first time, a new AGE that uses denaturing conditions (SDS-AGE) for analysis of urinary protein in patients with MM. IFE is the reference method for detection and identification of monoclonal free light chains (Bence Jones proteins), but cannot be used to screen a large number of urinary samples for BJP (1). Despite high sensitivity, immunonephelometry should not be used for BJP quantification with potential under- or overestimation (19)(20)(21). Monoclonal proteins may react peculiarly with antisera produced against polyclonal populations of immunoglobulins and light chains (21). Moreover, insufficient information is presently available regarding the usefulness of measuring the urinary {kappa}/{lambda} ratio for BJP identification (17).

Electrophoresis and densitometric scanning of the gel is the best available method for both screening and a quantitative approach for measurement of urinary BJP. Routine (nondenaturing) AGE, however, cannot differentiate Bence Jones proteins from intact Ig and shows poor sensitivity for BJP detection. A prior concentration step is required, but there is no agreement on the ideal concentration that should be obtained for BJP screening (22)(23). In our experience, concentrating urine more than 25-fold leads to excessive background staining. Concentrating urine up to 100-fold or more is time-consuming and not necessarily associated with a gain in sensitivity for BJP detection, with the exception of glomerular proteinuria and pure BJP (Table 2Up , patients 1 and 5). In addition, prior concentration of urine by ultrafiltration is associated with a loss of low Mr proteins (24), leading to a 30% overestimation of the albumin fraction, compared with immunonephelometry.

SDS-AGE separates proteins according to their molecular mass and does not require prior urine concentration, a substantial improvement over routine electrophoresis. We obtained excellent reproducibility of the Rf (CV <5%, n = 9) of identical proteins (LMW calibrator). These results compare favorably with those obtained with SDS-PAGE (8) or AGE (25). Quantitation of light chains also showed excellent within-run and day-to-day precision (CV <5%) and correlated well (P <0.001) with other methods. In MM patients, BJP results from tubular overload because of excessive synthesis. Under reducing conditions, Bence Jones proteins appear as a single dense band at Mr 25 000, and were not confused with polyclonal light chains in a large majority of cases (three false positives). In terms of sensitivity, SDS-AGE is clearly superior to routine electrophoresis for BJP detection (97% vs 87%) with a sensitivity close to IFE. Interestingly, one false positive (Table 2Up , patient 6) with glomerular proteinuria (total protein, 80 mg/L; 40% as light chains) had a {kappa}/{lambda} ratio outside the reference interval (0.33), strongly suggesting BJP. In some cases, SDS-AGE might show higher sensitivity than IFE for detecting Bence Jones proteins at low concentrations.

SDS-PAGE is a powerful tool for monitoring kidney function (8). For example, SDS-PAGE protein patterns can help elucidate the predominant renal lesion when a biopsy is not possible, such as in children or the elderly (13). In our group of MM patients, SDS-AGE easily differentiated glomerular (selective or not selective), from tubular or mixed proteinuria. Only 26% of MM patients had no signs of renal impairment. Renal failure (acute or chronic) is one of the major complications of MM (26). Renal impairment is observed in ~50% of MM patients during the course of their disease and has been associated with a poor prognosis. Interestingly, most of the severe cases of renal impairment (plasma creatinine >200 µmol/L) were found in patients with mixed proteinuria (43%), rather than in those with glomerular (15%) or tubular (20%) proteinuria or prerenal BJP (7%), identified by SDS-AGE. Light chain excretion has been described as an essential factor contributing to renal failure in MM (26). However, we did not find any relation between light chain proteinuria (determined by SDS-AGE) and renal failure.

A few limitations of the SDS-AGE technique should be emphasized. The most important is that SDS-AGE has no definitive way to distinguish between monoclonal and polyclonal proteins. In the absence of tubular damage (pure BJP or glomerular proteinuria, 50% of our MM samples), we found that a band at Mr 25 000 is always BJP. During tubular or mixed proteinuria, polyclonal light chains are excreted in the urine because of impairment of tubular reabsorption. Because MM can cause tubular damage, a complex mixture of monoclonal and polyclonal light chains may be excreted. We found that a band at Mr 25 000 of greater intensity than other small proteins ({alpha}1-microglobulin, retinol-binding protein, and ß2-microglobulin) strongly suggests BJP. In patients with tubular or mixed proteinuria, we obtained only two false positives with SDS-AGE, compared with both IFE and immunonephelometry. The presence of substantial quantities of polyclonal light chains in these specimens, however, likely leads to an overestimation of the amount of BJP, as underscored by others (27). In addition, in our IFE negative control group we verified that the SDS-AGE protein pattern produced by polyclonal light chains observed during tubular or mixed proteinuria is unlikely to be confused with monoclonal components (no false positives).

Other difficulties encountered with SDS-AGE are associated with BJP quantitation. Polymeric forms of light chains were present as high Mr bands (>=300 000), smears, or dimers (Mr 50 000) in 50% of our MM urine specimens. Comigration of polymers with albumin on the gel can be suspected by comparing electrophoretic protein patterns with the results of albuminuria (by immunonephelometry) and/or dipstick tests (light chains do not react with tetrabromophenol). Frequencies of 80% for dimers, 30% for tetramers, 20% for higher polymers, and 25% for fragments of Bence Jones proteins have been reported (27). If a large number of MM patients need to be evaluated, we recommend reducing all urinary samples with ß-ME before SDS-AGE, with a depolymerization marker run in parallel. We verified that there is no impact of ß-ME treatment on the Rf of other proteins. Finally, it should be recalled that there is no reference method for estimation of total urinary protein: the biuret method lacks sufficient sensitivity for most urine samples (2). We used an improved SDS-pyrogallol red-molybdate technique, equally sensitive to albumin and {gamma}-globulin (15)(16). Alternatively, results might be expressed in percentage of total proteinuria, instead of in mg/L.

In conclusion, SDS-AGE appears to be a clinical tool for the laboratory follow-up of MM patients. SDS-AGE has high resolution, sensitivity, and reproducibility. In a specialized laboratory like ours, it is useful for monitoring patient progress through the semiquantitation of BJP. Compared with routine electrophoresis, SDS-AGE combines no need for prior urine concentration with increased sensitivity for BJP detection. Glomerular, tubular, and mixed patterns were easily identified on the gel. Interpreting SDS-AGE protein patterns requires, however, awareness of some pitfalls, especially with regard to light chain polymerization and the presence of mono- and/or polyclonal light chains in urine specimens from MM patients.


   Acknowledgments
 
We thank all the technical staff in our laboratory for their technical expertise.


   Footnotes
 
1 Nonstandard abbreviations: MM, multiple myeloma; IFE, immunofixation; BJP, Bence Jones proteinuria; AGE, agarose gel electrophoresis; SDS, sodium dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis; Mr, molecular weight; ß-ME, ß-mercaptoethanol; and Rf, relative mobility.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Levinson SS, Keren DF. Free light chains of immunoglobulins: clinical laboratory analysis. Clin Chem 1994;40:1869-1878. [Abstract/Free Full Text]
  2. Kyle RA. The monoclonal gammopathies. Clin Chem 1994;40:2154-2161. [Abstract]
  3. Riches P. Immunochemical investigations of lymphoid malignancies. In: Gooi HC, Chapel H, eds. Clinical immunology. A practical approach. IRL Press, Oxford, 1990:111–38..
  4. McLaughlin P, Alexanian R. Myeloma protein kinetics following chemotherapy. Blood 1982;60:851-855. [Abstract/Free Full Text]
  5. Pesce AJ, Boreisha I, Pollak VE. Rapid differentiation of glomerular and tubular proteinuria by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Clin Chim Acta 1972;40:27-34. [Web of Science][Medline] [Order article via Infotrieve]
  6. Laurell CB. Composition and variation of the gel electrophoretic fractions of plasma, cerebrospinal fluid and urine. J Clin Invest 1972;29(Suppl 124):71-82.
  7. McNamara EM, Aguzzi F, Petrini C, Higgison J, Gasparro C, Bergami MR, et al. Restricted electrophoretic heterogeneity of immunoglobulin light chains in urine: a cause for confusion with Bence Jones protein. Clin Chem 1991;37:1570-1574. [Abstract/Free Full Text]
  8. Bianchi-Bosisio A, D'Agrosa F, Gaboardi F, Gianazza E, Righetti PG. Sodium dodecyl sulphate electrophoresis of urinary proteins. J Chromatogr 1991;569:243-260. [Web of Science][Medline] [Order article via Infotrieve]
  9. Burton C, Harris KP. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 1996;27:765-775. [Web of Science][Medline] [Order article via Infotrieve]
  10. Durie BGM, Salmon SE. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842-854. [Web of Science][Medline] [Order article via Infotrieve]
  11. Marshall T, Williams KM. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis of urine: concentration of urinary proteins by precipitation with coomassie blue. Clin Chem 1993;39:2314-2318. [Web of Science][Medline] [Order article via Infotrieve]
  12. Siba KS, Kanamori K, Cho H, Furuhata N, Harada T, Shiba A, Nakao M. Re-evaluation of normal urinary proteins fractionated by one-dimensional sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Clin Chim Acta 1988;172:77-84. [Web of Science][Medline] [Order article via Infotrieve]
  13. Lubega J. Evaluation of urinary proteins by sodium dodecyl sulphate polyacrylamide disc gel electrophoresis and molecular mass analysis. Clin Chim Acta 1983;128:151-167. [Web of Science][Medline] [Order article via Infotrieve]
  14. Marshall T, Williams KM. Simplified sodium dodecyl sulphate-polyacrylamide gel electrophoresis of unconcentrated urine with enhanced resolution and detection sensitivity. Clin Chem 1987;33:1886-1887. [Abstract/Free Full Text]
  15. Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, Tokuda K. Urinary protein as measurement with a pyrogallol red-molybdate complex, manually and in Hitachi 726 automated analyzer. Clin Chem 1986;32:1551-1554. [Abstract/Free Full Text]
  16. Orsonneau JL, Douet P, Massoubre C, Lustenberger P, Bernard S. An improved pyrogallol red-molybdate method for determining total urinary protein. Clin Chem 1989;35:2233-2236. [Abstract/Free Full Text]
  17. Boege F, Koehler B, Liebermann F. Identification and quantification of Bence Jones proteinuria by automated nephelometric screening. J Clin Chem Clin Biochem 1990;28:37-42. [Web of Science][Medline] [Order article via Infotrieve]
  18. Doumas BT, Peters T. Serum and urine albumin: a progress report on their measurement and clinical significance. Clin Chim Acta 1997;258:3-20. [Web of Science][Medline] [Order article via Infotrieve]
  19. Levinson SS. Studies of Bence Jones proteins by immunonephelometry. Ann Clin Lab Sci 1992;22:100-109. [Abstract]
  20. Hess PP, Mastropoulo W, Thompson GD, Levinson SS. Interference by polyclonal free light chains with identification of Bence Jones proteins. Clin Chem 1993;39:1734-1738. [Abstract]
  21. Bush D, Keren DF. Over and underestimation of monoclonal gammopathies by quantitation of kappa- and lambda-containing immunoglobulins in serum. Clin Chem 1992;38:315-316. [Free Full Text]
  22. Pascalli E. Urine collection for the detection of Bence Jones proteinuria. Am J Clin Pathol 1991;95:266-267. [Web of Science][Medline] [Order article via Infotrieve]
  23. Bridgen ML, Neal ED, McNeely MDD, Hoag GN. The optimum urine collections and monitoring of Bence Jones proteinuria. Am J Clin Pathol 1990;93:689-693. [Web of Science][Medline] [Order article via Infotrieve]
  24. Pesce AJ, Hsu A, Kornhauser C, Sethi K, Ooi S, Pollak VE. Method for measuring the concentration of urinary proteins according to their molecular size category. Clin Chem 1976;22:667-672. [Abstract/Free Full Text]
  25. Zakharov SF, Chang HT, Chrambach A. Reproducibility of mobility in gel electrophoresis. Electrophoresis 1996;17:84-90. [Web of Science][Medline] [Order article via Infotrieve]
  26. Alexanian R, Barlogie B, Dixon D. Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 1990;150:1693-1695. [Abstract/Free Full Text]
  27. Norden AGW, Fulcher LM, Flynn FV. Immunoglobulin light-chain immunoblots of urine proteins from patients with tubular and Bence Jones proteinuria. Clin Chim Acta 1987;166:307-315. [Web of Science][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. Gai, V. Cantaluppi, C. Fenocchio, D. Motta, S. Masini, A. Pacitti, and G. Lanfranco
Presence of Protein Fragments in Urine of Critically Ill Patients with Acute Renal Failure: A Nephrologic Enigma
Clin. Chem., October 1, 2004; 50(10): 1822 - 1824.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Salomo, P. Gimsing, and L. B. Nielsen
Simple Method for Quantification of Bence Jones Proteins
Clin. Chem., December 1, 2002; 48(12): 2202 - 2207.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Matsuda, N. Hiratsuka, T. Koyama, Y. Kurihara, O. Hotta, Y. Itoh, and K. Shiba
Sensitive Method for Detection and Semiquantification of Bence Jones Protein by Cellulose Acetate Membrane Electrophoresis Using Colloidal Silver Staining
Clin. Chem., April 1, 2001; 47(4): 763 - 766.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. F. Keren
Detection and Characterization of Monoclonal Componentsin Serum and Urine
Clin. Chem., June 1, 1998; 44(6): 1143 - 1145.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Bricon, T.
Right arrow Articles by Bousquet, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Bricon, T.
Right arrow Articles by Bousquet, B.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS